Immuneering Corporation
PublicLast Round
Private Placement
Sep 26, 2025
Total Funding Raised
$433.4M
Company Overview
Immuneering (NAS: IMRX) is a biopharmaceutical company dedicated to enhancing patient outcomes in challenging oncologic and neurologic diseases through its advanced computational Disease Cancelling Technology platform and expertise in translational bioinformatics.
Sector
Healthcare
AI Layer
Infrastructure
Keywords
atebimetinib (IMM-1-104)deep cyclic inhibition of the MAPK pathwayoral MEK inhibitor for solid tumorsDisease Canceling Technology (DCT) platformRAS-mutant solid tumor therapycomputational drug discovery platformoral small molecule drugs for cancertranslational bioinformatics for drug discoverycomputational biology services for pharmabiomarker discovery servicesdrug target identification servicespancreatic cancer therapeuticsneurological disease drug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immuneering Corporation Comps
Public and private peers based on sector, stage, and business model.
Immuneering Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 26, 2025 | ||||
| Follow-on Offering | Sep 26, 2025 | ||||
| Private Placement | Aug 26, 2025 | ||||
| IPO Announced | Aug 3, 2021 | ||||
| Series B | Jan 5, 2021 | ||||
Series A | Oct 4, 2019 |
Immuneering Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Perceptive Advisors | Series B |
| Guggenheim Securities | IPO |
| LYFE Capital | Series B |
| Counterpoint Global (Morgan Stanley) | IPO |
| T. Rowe Price | Series B |
| Citadel | Series B |
Immuneering Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersCambridge, Massachusetts
Employee Range57
Year Founded2008
Last FundingSep 26, 2025
